AK

Apurva Krishna Chaulwar

Active Director Director DIN 11321824
DIN 11321824 First appointment Sep 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Apurva Krishna Chaulwar

Data last updated:

Apurva Krishna Chaulwar is a Director at Polarex Drugs Private Limited (since 2025).

DIN 11321824
Primary Designation Director
First Appointment 29 Sep 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Polarex Drugs Private Limited U21001MH2025PTC458154
Director29 Sep 20252025Active

Board colleagues of Apurva Krishna Chaulwar

NameDINCompanyDesignation
Prakash Sangamnath Mankulwar11321823Polarex Drugs Private LimitedDirector

Directorship timeline

Open interactive timeline →
Polarex Drugs Private Limited
Premium access

Shareholding and investment profile for Apurva Krishna Chaulwar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Apurva Krishna Chaulwar

Apurva Krishna Chaulwar currently holds 1 directorship: Polarex Drugs Private Limited (Director, since 29 Sep 2025).

Apurva Krishna Chaulwar was first appointed on 29 Sep 2025 as Director at Polarex Drugs Private Limited.

The current boards of Apurva Krishna Chaulwar's companies include Prakash Sangamnath Mankulwar (Polarex Drugs Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available